Breathing Life into Immunization Policies: Actions That Enhance RSV Prevention in Infants

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness globally and a major driver of hospitalization in infants under one year. The introduction of RSV immunization for infants in some countries—and active consideration in others—creates a timely opportunity to strengthen prevention policies. This panel will examine how to secure sustainable financing, integrate RSV prevention into existing national immunization programs, improve surveillance, and raise awareness. Policymakers, patient advocates, and implementation experts will share lessons learned and best practices to support timely, equitable, and sustainable RSV immunization programs across diverse health system settings.